Resmetirom and Semaglutide for MASH in 2025: Updated recommendations from AASLD Guidance
Moderator: Robert Fontana
This session will address MASLD/ MASH 2025 needs regarding available treatment options for MASLD...
Moderator: Robert Fontana
This session will address MASLD/ MASH 2025 needs regarding available treatment options for MASLD...
For more event information, please visit here.
For more event information, please visit here.
AASLD develops evidence-based practice guidelines which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. AASLD also provides practice tools to assist with learning and implementing the new recommendations.